Why Regulus Therapeutics Stock Jumped Over 33%: Breakthrough Trial Results Drive Surge
Regulus Therapeutics (NASDAQ: RGLS) witnessed a sharp rally today, with shares surging more than 33%, jumping from $2.76 to around $3.68 intraday. The biotech company's remarkable rise is fueled by…